Viewpoint Capital Management’s Merck MRK Stock Holding History

Viewpoint Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$197K	Sell	1,532 -2,012	-57%	-$236K	0.1%	92
2026 Q1	$426K	Buy	3,544 +1	+0%	+$115	0.2%	72
2025 Q4	$373K	Sell	3,543 -28	-0.8%	-$2.63K	0.16%	81
2025 Q3	$300K	Buy	3,571 +32	+0.9%	+$2.64K	0.13%	87
2025 Q2	$280K	Sell	3,539 -246	-6%	-$19.6K	0.14%	86
2025 Q1	$340K	Buy	3,785 +15	+0.4%	+$1.4K	0.18%	83
2024 Q4	$375K	Hold	3,770	–	–	0.2%	75
2024 Q3	$429K	Hold	3,770	–	–	0.24%	68
2024 Q2	$467K	Buy	3,770 +253	+7%	+$32.6K	0.29%	61
2024 Q1	$464K	Hold	3,517	–	–	0.3%	61
2023 Q4	$383K	Hold	3,517	–	–	0.27%	66
2023 Q3	$362K	Hold	3,517	–	–	0.29%	65
2023 Q2	$406K	Buy	3,517 +1,050	+43%	+$119K	0.31%	61
2023 Q1	$262K	Hold	2,467	–	–	0.24%	72
2022 Q4	$274K	Hold	2,467	–	–	0.26%	70
2022 Q3	$212K	Hold	2,467	–	–	0.21%	74
2022 Q2	$225K	Hold	2,467	–	–	0.21%	73
2022 Q1	$202K	Buy	+2,467	New	+$195K	0.16%	84

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Viewpoint Capital Management's MRK Position: Q2 2026 in Review

Viewpoint Capital Management reduced its Merck (MRK) stake by 57% in Q2 2026, selling an estimated $236K and leaving 1,532 shares worth $197K. The position accounts for 0.1% of the portfolio, ranked #92.

Viewpoint Capital Management first reported a position in MRK in Q1 2022 and has held it in 18 quarters since. The position peaked at $467K in Q2 2024. 3,847 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Viewpoint Capital Management held 1,532 shares of Merck worth $197K as of Q2 2026.
Viewpoint Capital Management sold 2,012 Merck shares in Q2 2026, an estimated $236K.
Merck made up 0.1% of Viewpoint Capital Management's portfolio in Q2 2026, its #92 holding.
Viewpoint Capital Management first reported a position in Merck in Q1 2022 and has held it in 18 quarters since.
Viewpoint Capital Management's Merck position peaked at $467K in Q2 2024.
3,847 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Viewpoint Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.